PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Mammea B/BA isolated from seeds is a potent inhibitor with MIC values between 0.5 and 1.0 μg/ml [PMID:35359842].
Fifteen isoprenylated coumarins from seeds exhibited significant cytotoxic activities (IC50 ranges 10.7 - 88.1 μM) [PMID:16206041].
Mammea A/AA obtained from fruit peels showed trypanocidal activity with MC100 values in the range of 15 to 90 μg/ml [PMID:18797754].
Ethanolic seed extracts showed antibacterial activity with MBC from 2.3 μg/ml [PMID:37700878].
Crude extract and green synthesized silver nanoparticles from leaves were evaluated for anthelmintic activity [PMID:39145363].
Evidence summary
PubMed sources
- 1.PMID: 38611875 (2024) — Characterization of Crude and Processed Pulp Cell Walls of Three Selected Mamey Accessions (Mammea americana L.). · Molecules (Basel, Switzerland)
- 2.PMID: 35359842 (2022) — Mammea B/BA Isolated From the Seeds of Mammea americana L. (Calophyllaceae) is a Potent Inhibitor of Methicillin-Resistant Staphylococcus aureus. · Frontiers in pharmacology
- 3.PMID: 16756334 (2006) — Comparative analyses of bioactive Mammea coumarins from seven parts of Mammea americana by HPLC-PDA with LC-MS. · Journal of agricultural and food chemistry
- 4.PMID: 31952109 (2020) — Metabolite Profiling by UPLC-MSE, NMR, and Antioxidant Properties of Amazonian Fruits: Mamey Apple (Mammea Americana), Camapu (Physalis Angulata), and Uxi (Endopleura Uchi). · Molecules (Basel, Switzerland)
- 5.PMID: 16206041